Eastern Cooperative Oncology Group score: Agreement between non-small-cell lung cancer patients and their oncologists and clinical implications

Small Cell ◽

Clinical Implications ◽

Oncology Group ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Group Score

Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e31829cf942 ◽

2013 ◽

Vol 8 (9) ◽

pp. 1121-1127 ◽

Cited By ~ 49

Author(s):

Suzanne E. Dahlberg ◽

Joan H. Schiller ◽

Philip B. Bonomi ◽

Alan B. Sandler ◽

Julie R. Brahmer ◽

...

Keyword(s):

Lung Cancer ◽

Body Mass Index ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594

Lung Cancer ◽

10.1016/j.lungcan.2013.03.018 ◽

2013 ◽

Vol 81 (1) ◽

pp. 47-52 ◽

Cited By ~ 9

Author(s):

Tien Hoang ◽

Suzanne E. Dahlberg ◽

Joan H. Schiller ◽

David H. Johnson

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Oncology Group Study ◽

Faculty Opinions recommendation of Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1097586.553672 ◽

2008 ◽

Author(s):

Jack West

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Advanced Stage ◽

Oncology Group ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Group Trial

Clinical Implications of High MET Gene Dosage in Non-Small Cell Lung Cancer Patients without Previous Tyrosine Kinase Inhibitor Treatment

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3182307e92 ◽

2011 ◽

Vol 6 (12) ◽

pp. 2027-2035 ◽

Cited By ~ 12

Author(s):

Ya-Ting Chen ◽

John Wen-Cheng Chang ◽

Hui-Ping Liu ◽

Tsung-Fu Yu ◽

Yu-Ting Chiu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Gene Dosage ◽

Small Cell ◽

Clinical Implications ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Inhibitor Treatment

Analysis of the clinical implications of c-kit expression in small cell lung cancer patients (SCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7164 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7164-7164

Author(s):

A. Carrato ◽

C. Camps ◽

R. Sirera ◽

M. J. Safont ◽

J. Garde ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Clinical Implications ◽

Small Cell Lung ◽

Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients

JCI Insight ◽

10.1172/jci.insight.59125 ◽

2018 ◽

Vol 3 (19) ◽

Cited By ~ 40

Author(s):

Akio Osa ◽

Takeshi Uenami ◽

Shohei Koyama ◽

Kosuke Fujimoto ◽

Daisuke Okuzaki ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Clinical Implications ◽

Small Cell Lung ◽

Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study)

Oncotarget ◽

10.18632/oncotarget.11303 ◽

2016 ◽

Vol 7 (36) ◽

pp. 58492-58499 ◽

Cited By ~ 40

Author(s):

Takayuki Takahama ◽

Kazuko Sakai ◽

Masayuki Takeda ◽

Koichi Azuma ◽

Toyoaki Hida ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitors ◽

Acquired Resistance ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

T790m Mutation ◽

Biological and Clinical Implications of Functional Promoter Polymorphism of CASPASE 9 Gene in Non Small Cell Lung Cancer Patients

Journal of Molecular Biomarkers & Diagnosis ◽

10.4172/2155-9929.s8-007 ◽

2012 ◽

Vol S8 ◽

Author(s):

Jamsheed Javid

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Promoter Polymorphism ◽

Small Cell ◽

Clinical Implications ◽

Small Cell Lung ◽

Caspase 9 ◽

277 Analysis of c-kit expression in small cell lung cancer patients and its clinical implications

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)80285-4 ◽

2004 ◽

Vol 2 (8) ◽

pp. 85

Author(s):

R. Sirera ◽

M. Martin ◽

P. Bayo ◽

A. Blasco ◽

M.J. Safont ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Clinical Implications ◽

Small Cell Lung ◽

Sequential Vinorelbine and Docetaxel in Advanced Non-small Cell Lung Cancer Patients Age 70 and Older and/or with a Performance Status of 2: A Phase II Trial of the Southwest Oncology Group (S0027)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(15)30356-7 ◽

2006 ◽

Vol 1 (6) ◽

pp. 537-544 ◽

Cited By ~ 5

Author(s):

Paul J. Hesketh ◽

Kari Chansky ◽

Derick H.M. Lau ◽

James H. Doroshow ◽

Carol M. Moinpour ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii Trial ◽

Performance Status ◽

Small Cell ◽

Oncology Group ◽

Small Cell Lung ◽

Southwest Oncology Group ◽